Kawasaki Disease

Pediatrics / Rheumatology

Overview

Definition

An acute, self-limiting systemic vasculitis of unknown etiology that predominantly affects children < 5 years of age.

Epidemiology

Highest incidence in children of Asian descent.

Etiology & Risk Factors

  • Unknown. Suspected to be an aberrant immune response to an infectious trigger in genetically predisposed children.

Clinical Symptoms

  • CRASH and Burn: Conjunctivitis (bilateral, non-exudative)
  • Rash (polymorphous, primarily on the trunk)
  • Adenopathy (cervical, >1.5 cm, usually unilateral)
  • Strawberry tongue and cracked red lips
  • Hands and feet (erythema, edema, subsequent desquamation)
  • Burn: Fever lasting ≥ 5 days

Clinical Approach

Diagnosis

  • Clinical diagnosis requiring fever for ≥ 5 days plus 4 of the 5 'CRASH' criteria
  • Echocardiogram is MANDATORY to evaluate for coronary artery aneurysms
  • Labs: Elevated ESR/CRP, Thrombocytosis (often > 500,000) in the subacute phase

Management

  • Intravenous Immunoglobulin (IVIG) as a single high dose (reduces risk of aneurysms from 25% to < 5%)
  • High-dose Aspirin (for anti-inflammatory and anti-platelet effects, despite the theoretical risk of Reye syndrome)

Complications

  • Coronary artery aneurysms (can lead to myocardial infarction in young children)
  • Myocarditis
  • Macrophage Activation Syndrome (MAS)